Unmet Need in the IRA Drug Price Negotiation Program Read more about Unmet Need in the IRA Drug Price Negotiation Program
The Impact of the Inflation Reduction Act’s Drug Pricing Negotiation Program on Incentives for Clinical Development of New Drugs Read more about The Impact of the Inflation Reduction Act’s Drug Pricing Negotiation Program on Incentives for Clinical Development of New Drugs
New NPC Analysis Illustrates How IRA’s Medicare Drug Price Negotiation Program May Reshape Pharmaceutical R&D Incentives Read more about New NPC Analysis Illustrates How IRA’s Medicare Drug Price Negotiation Program May Reshape Pharmaceutical R&D Incentives
New NPC Research Examines Challenges and Holistic Solutions for Improving Patient Access to Gene Therapies Read more about New NPC Research Examines Challenges and Holistic Solutions for Improving Patient Access to Gene Therapies
Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States Read more about Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States
Paying for Curative Therapies: Our Challenges in Addressing Medicine’s Solutions Read more about Paying for Curative Therapies: Our Challenges in Addressing Medicine’s Solutions
Are Payers Ready to Address the Financial Challenges Associated With Gene Therapy? Read more about Are Payers Ready to Address the Financial Challenges Associated With Gene Therapy?